世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

心臓臓器チップの世界市場成長 2023-2029


Global Heart Organ Chip Market Growth 2023-2029

弊社（LP Info Research）の最新調査によると、世界の心臓臓器チップ市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、心臓臓器... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2023年8月2日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		102 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

弊社（LP Info Research）の最新調査によると、世界の心臓臓器チップ市場規模は2022年に100万米ドルと評価されました。川下市場での需要拡大とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、心臓臓器チップは2029年までに100万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは%である。
この調査レポートは、世界の心臓臓器チップ市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復により、心臓臓器チップは今後の市場で安定した成長を示すと予想される。しかし、心臓臓器チップの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、心臓臓器チップ市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要がある。
心臓臓器チップは、マイクロチップ製造法によって作製されたマイクロ流体細胞培養デバイスであり、薬剤スクリーニングや個別化治療のための効果的なプラットフォームである。
主な特徴
この調査レポートは、心臓臓器チップ市場を様々な側面から分析し、業界に関する貴重な洞察を提供しています。
市場規模と成長：この調査レポートは、心臓臓器チップ市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分（電気的刺激を与える、機械的刺激を与えるなど）、地域別内訳などが含まれます。
市場促進要因と課題：政府規制、環境問題、技術進歩、消費者嗜好の変化など、心臓臓器チップ市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができる。
競合情勢：この調査レポートは、心臓臓器チップ市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発：調査レポートは、心臓臓器チップ産業における最新の技術開発を掘り下げることができます。これには、心臓臓器チップ技術の進歩、心臓臓器チップの新規参入、心臓臓器チップの新規投資、心臓臓器チップの将来を形作るその他の技術革新が含まれます。
川下の事業者の好み：このレポートは、心臓臓器チップ市場における顧客の購買行動と採用動向を明らかにすることができます。顧客の購買決定、心臓臓器チップ製品の嗜好に影響を与える要因も含まれる。
政府の政策とインセンティブ：調査レポートは、政府の政策やインセンティブが心臓臓器チップ市場に与える影響を分析します。これには、心臓臓器チップ市場の促進を目的とした規制枠組み、補助金、税制優遇措置、その他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性調査レポートは、心臓臓器チップ市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望：実施した分析に基づいて、調査レポートは心臓臓器チップ産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、心臓臓器チップ市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場細分化：
心臓臓器チップ市場は、タイプ別と用途別に分類されます。2018年から2029年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
電気的刺激を与える
機械的刺激を与える
その他
用途別セグメント
創薬
疾患モデルの構築
免疫応答療法
その他
本レポートではまた、市場を地域別に分けています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
エルベシス
エミュレート
TissUse GmbH
CNバイオ・イノベーションズ
ミメタス
インスパイロ
アセンダンス・バイオ
アクソシム
ヒューレル
シンビボ
ノーティス・バイオ
本レポートで扱う主な質問
世界の心臓臓器チップ市場の10年展望は？
世界および地域別の心臓臓器チップ市場成長の要因は何か？
市場別、地域別に最も急成長する技術は何か？
心臓臓器チップの市場機会は最終市場規模によってどのように異なるのか？
心臓臓器チップのタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響は？


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heart Organ Chip Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Heart Organ Chip by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Heart Organ Chip by Country/Region, 2018, 2022 & 2029
2.2 Heart Organ Chip Segment by Type
2.2.1 Give Electrical Stimulation
2.2.2 Give Mechanical Stimulation
2.2.3 Others
2.3 Heart Organ Chip Sales by Type
2.3.1 Global Heart Organ Chip Sales Market Share by Type (2018-2023)
2.3.2 Global Heart Organ Chip Revenue and Market Share by Type (2018-2023)
2.3.3 Global Heart Organ Chip Sale Price by Type (2018-2023)
2.4 Heart Organ Chip Segment by Application
2.4.1 Drug Discovery
2.4.2 Disease Model Construction
2.4.3 Immune Response Therapy
2.4.4 Others
2.5 Heart Organ Chip Sales by Application
2.5.1 Global Heart Organ Chip Sale Market Share by Application (2018-2023)
2.5.2 Global Heart Organ Chip Revenue and Market Share by Application (2018-2023)
2.5.3 Global Heart Organ Chip Sale Price by Application (2018-2023)
3 Global Heart Organ Chip by Company
3.1 Global Heart Organ Chip Breakdown Data by Company
3.1.1 Global Heart Organ Chip Annual Sales by Company (2018-2023)
3.1.2 Global Heart Organ Chip Sales Market Share by Company (2018-2023)
3.2 Global Heart Organ Chip Annual Revenue by Company (2018-2023)
3.2.1 Global Heart Organ Chip Revenue by Company (2018-2023)
3.2.2 Global Heart Organ Chip Revenue Market Share by Company (2018-2023)
3.3 Global Heart Organ Chip Sale Price by Company
3.4 Key Manufacturers Heart Organ Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heart Organ Chip Product Location Distribution
3.4.2 Players Heart Organ Chip Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Heart Organ Chip by Geographic Region
4.1 World Historic Heart Organ Chip Market Size by Geographic Region (2018-2023)
4.1.1 Global Heart Organ Chip Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Heart Organ Chip Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Heart Organ Chip Market Size by Country/Region (2018-2023)
4.2.1 Global Heart Organ Chip Annual Sales by Country/Region (2018-2023)
4.2.2 Global Heart Organ Chip Annual Revenue by Country/Region (2018-2023)
4.3 Americas Heart Organ Chip Sales Growth
4.4 APAC Heart Organ Chip Sales Growth
4.5 Europe Heart Organ Chip Sales Growth
4.6 Middle East & Africa Heart Organ Chip Sales Growth
5 Americas
5.1 Americas Heart Organ Chip Sales by Country
5.1.1 Americas Heart Organ Chip Sales by Country (2018-2023)
5.1.2 Americas Heart Organ Chip Revenue by Country (2018-2023)
5.2 Americas Heart Organ Chip Sales by Type
5.3 Americas Heart Organ Chip Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heart Organ Chip Sales by Region
6.1.1 APAC Heart Organ Chip Sales by Region (2018-2023)
6.1.2 APAC Heart Organ Chip Revenue by Region (2018-2023)
6.2 APAC Heart Organ Chip Sales by Type
6.3 APAC Heart Organ Chip Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Heart Organ Chip by Country
7.1.1 Europe Heart Organ Chip Sales by Country (2018-2023)
7.1.2 Europe Heart Organ Chip Revenue by Country (2018-2023)
7.2 Europe Heart Organ Chip Sales by Type
7.3 Europe Heart Organ Chip Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heart Organ Chip by Country
8.1.1 Middle East & Africa Heart Organ Chip Sales by Country (2018-2023)
8.1.2 Middle East & Africa Heart Organ Chip Revenue by Country (2018-2023)
8.2 Middle East & Africa Heart Organ Chip Sales by Type
8.3 Middle East & Africa Heart Organ Chip Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heart Organ Chip
10.3 Manufacturing Process Analysis of Heart Organ Chip
10.4 Industry Chain Structure of Heart Organ Chip
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heart Organ Chip Distributors
11.3 Heart Organ Chip Customer
12 World Forecast Review for Heart Organ Chip by Geographic Region
12.1 Global Heart Organ Chip Market Size Forecast by Region
12.1.1 Global Heart Organ Chip Forecast by Region (2024-2029)
12.1.2 Global Heart Organ Chip Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Heart Organ Chip Forecast by Type
12.7 Global Heart Organ Chip Forecast by Application
13 Key Players Analysis
13.1 Elvesys
13.1.1 Elvesys Company Information
13.1.2 Elvesys Heart Organ Chip Product Portfolios and Specifications
13.1.3 Elvesys Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Elvesys Main Business Overview
13.1.5 Elvesys Latest Developments
13.2 Emulate
13.2.1 Emulate Company Information
13.2.2 Emulate Heart Organ Chip Product Portfolios and Specifications
13.2.3 Emulate Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Emulate Main Business Overview
13.2.5 Emulate Latest Developments
13.3 TissUse GmbH
13.3.1 TissUse GmbH Company Information
13.3.2 TissUse GmbH Heart Organ Chip Product Portfolios and Specifications
13.3.3 TissUse GmbH Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TissUse GmbH Main Business Overview
13.3.5 TissUse GmbH Latest Developments
13.4 CN Bio Innovations
13.4.1 CN Bio Innovations Company Information
13.4.2 CN Bio Innovations Heart Organ Chip Product Portfolios and Specifications
13.4.3 CN Bio Innovations Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CN Bio Innovations Main Business Overview
13.4.5 CN Bio Innovations Latest Developments
13.5 Mimetas
13.5.1 Mimetas Company Information
13.5.2 Mimetas Heart Organ Chip Product Portfolios and Specifications
13.5.3 Mimetas Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mimetas Main Business Overview
13.5.5 Mimetas Latest Developments
13.6 Insphero
13.6.1 Insphero Company Information
13.6.2 Insphero Heart Organ Chip Product Portfolios and Specifications
13.6.3 Insphero Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Insphero Main Business Overview
13.6.5 Insphero Latest Developments
13.7 Ascendance Bio
13.7.1 Ascendance Bio Company Information
13.7.2 Ascendance Bio Heart Organ Chip Product Portfolios and Specifications
13.7.3 Ascendance Bio Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ascendance Bio Main Business Overview
13.7.5 Ascendance Bio Latest Developments
13.8 Axosim
13.8.1 Axosim Company Information
13.8.2 Axosim Heart Organ Chip Product Portfolios and Specifications
13.8.3 Axosim Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Axosim Main Business Overview
13.8.5 Axosim Latest Developments
13.9 Hurel
13.9.1 Hurel Company Information
13.9.2 Hurel Heart Organ Chip Product Portfolios and Specifications
13.9.3 Hurel Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hurel Main Business Overview
13.9.5 Hurel Latest Developments
13.10 Synvivo
13.10.1 Synvivo Company Information
13.10.2 Synvivo Heart Organ Chip Product Portfolios and Specifications
13.10.3 Synvivo Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Synvivo Main Business Overview
13.10.5 Synvivo Latest Developments
13.11 Nortis Bio
13.11.1 Nortis Bio Company Information
13.11.2 Nortis Bio Heart Organ Chip Product Portfolios and Specifications
13.11.3 Nortis Bio Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Nortis Bio Main Business Overview
13.11.5 Nortis Bio Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

According to our (LP Info Research) latest study, the global Heart Organ Chip market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Heart Organ Chip is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Heart Organ Chip market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Heart Organ Chip are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Heart Organ Chip. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Heart Organ Chip market.
Heart organ-on-a-chip, a microfluidic cell culture device fabricated by microchip fabrication methods, is an effective platform for drug screening and personalized therapy.
Key Features:
The report on Heart Organ Chip market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Heart Organ Chip market. It may include historical data, market segmentation by Type (e.g., Give Electrical Stimulation, Give Mechanical Stimulation), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Heart Organ Chip market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Heart Organ Chip market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Heart Organ Chip industry. This include advancements in Heart Organ Chip technology, Heart Organ Chip new entrants, Heart Organ Chip new investment, and other innovations that are shaping the future of Heart Organ Chip.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Heart Organ Chip market. It includes factors influencing customer ' purchasing decisions, preferences for Heart Organ Chip product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Heart Organ Chip market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Heart Organ Chip market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Heart Organ Chip market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Heart Organ Chip industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Heart Organ Chip market.
Market Segmentation:
Heart Organ Chip market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Give Electrical Stimulation
Give Mechanical Stimulation
Others
Segmentation by application
Drug Discovery
Disease Model Construction
Immune Response Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Elvesys
Emulate
TissUse GmbH
CN Bio Innovations
Mimetas
Insphero
Ascendance Bio
Axosim
Hurel
Synvivo
Nortis Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Heart Organ Chip market?
What factors are driving Heart Organ Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Heart Organ Chip market opportunities vary by end market size?
How does Heart Organ Chip break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Heart Organ Chip Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Heart Organ Chip by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Heart Organ Chip by Country/Region, 2018, 2022 & 2029
2.2 Heart Organ Chip Segment by Type
2.2.1 Give Electrical Stimulation
2.2.2 Give Mechanical Stimulation
2.2.3 Others
2.3 Heart Organ Chip Sales by Type
2.3.1 Global Heart Organ Chip Sales Market Share by Type (2018-2023)
2.3.2 Global Heart Organ Chip Revenue and Market Share by Type (2018-2023)
2.3.3 Global Heart Organ Chip Sale Price by Type (2018-2023)
2.4 Heart Organ Chip Segment by Application
2.4.1 Drug Discovery
2.4.2 Disease Model Construction
2.4.3 Immune Response Therapy
2.4.4 Others
2.5 Heart Organ Chip Sales by Application
2.5.1 Global Heart Organ Chip Sale Market Share by Application (2018-2023)
2.5.2 Global Heart Organ Chip Revenue and Market Share by Application (2018-2023)
2.5.3 Global Heart Organ Chip Sale Price by Application (2018-2023)
3 Global Heart Organ Chip by Company
3.1 Global Heart Organ Chip Breakdown Data by Company
3.1.1 Global Heart Organ Chip Annual Sales by Company (2018-2023)
3.1.2 Global Heart Organ Chip Sales Market Share by Company (2018-2023)
3.2 Global Heart Organ Chip Annual Revenue by Company (2018-2023)
3.2.1 Global Heart Organ Chip Revenue by Company (2018-2023)
3.2.2 Global Heart Organ Chip Revenue Market Share by Company (2018-2023)
3.3 Global Heart Organ Chip Sale Price by Company
3.4 Key Manufacturers Heart Organ Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Heart Organ Chip Product Location Distribution
3.4.2 Players Heart Organ Chip Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Heart Organ Chip by Geographic Region
4.1 World Historic Heart Organ Chip Market Size by Geographic Region (2018-2023)
4.1.1 Global Heart Organ Chip Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Heart Organ Chip Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Heart Organ Chip Market Size by Country/Region (2018-2023)
4.2.1 Global Heart Organ Chip Annual Sales by Country/Region (2018-2023)
4.2.2 Global Heart Organ Chip Annual Revenue by Country/Region (2018-2023)
4.3 Americas Heart Organ Chip Sales Growth
4.4 APAC Heart Organ Chip Sales Growth
4.5 Europe Heart Organ Chip Sales Growth
4.6 Middle East & Africa Heart Organ Chip Sales Growth
5 Americas
5.1 Americas Heart Organ Chip Sales by Country
5.1.1 Americas Heart Organ Chip Sales by Country (2018-2023)
5.1.2 Americas Heart Organ Chip Revenue by Country (2018-2023)
5.2 Americas Heart Organ Chip Sales by Type
5.3 Americas Heart Organ Chip Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Heart Organ Chip Sales by Region
6.1.1 APAC Heart Organ Chip Sales by Region (2018-2023)
6.1.2 APAC Heart Organ Chip Revenue by Region (2018-2023)
6.2 APAC Heart Organ Chip Sales by Type
6.3 APAC Heart Organ Chip Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Heart Organ Chip by Country
7.1.1 Europe Heart Organ Chip Sales by Country (2018-2023)
7.1.2 Europe Heart Organ Chip Revenue by Country (2018-2023)
7.2 Europe Heart Organ Chip Sales by Type
7.3 Europe Heart Organ Chip Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Heart Organ Chip by Country
8.1.1 Middle East & Africa Heart Organ Chip Sales by Country (2018-2023)
8.1.2 Middle East & Africa Heart Organ Chip Revenue by Country (2018-2023)
8.2 Middle East & Africa Heart Organ Chip Sales by Type
8.3 Middle East & Africa Heart Organ Chip Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Heart Organ Chip
10.3 Manufacturing Process Analysis of Heart Organ Chip
10.4 Industry Chain Structure of Heart Organ Chip
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Heart Organ Chip Distributors
11.3 Heart Organ Chip Customer
12 World Forecast Review for Heart Organ Chip by Geographic Region
12.1 Global Heart Organ Chip Market Size Forecast by Region
12.1.1 Global Heart Organ Chip Forecast by Region (2024-2029)
12.1.2 Global Heart Organ Chip Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Heart Organ Chip Forecast by Type
12.7 Global Heart Organ Chip Forecast by Application
13 Key Players Analysis
13.1 Elvesys
13.1.1 Elvesys Company Information
13.1.2 Elvesys Heart Organ Chip Product Portfolios and Specifications
13.1.3 Elvesys Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Elvesys Main Business Overview
13.1.5 Elvesys Latest Developments
13.2 Emulate
13.2.1 Emulate Company Information
13.2.2 Emulate Heart Organ Chip Product Portfolios and Specifications
13.2.3 Emulate Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Emulate Main Business Overview
13.2.5 Emulate Latest Developments
13.3 TissUse GmbH
13.3.1 TissUse GmbH Company Information
13.3.2 TissUse GmbH Heart Organ Chip Product Portfolios and Specifications
13.3.3 TissUse GmbH Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 TissUse GmbH Main Business Overview
13.3.5 TissUse GmbH Latest Developments
13.4 CN Bio Innovations
13.4.1 CN Bio Innovations Company Information
13.4.2 CN Bio Innovations Heart Organ Chip Product Portfolios and Specifications
13.4.3 CN Bio Innovations Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CN Bio Innovations Main Business Overview
13.4.5 CN Bio Innovations Latest Developments
13.5 Mimetas
13.5.1 Mimetas Company Information
13.5.2 Mimetas Heart Organ Chip Product Portfolios and Specifications
13.5.3 Mimetas Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mimetas Main Business Overview
13.5.5 Mimetas Latest Developments
13.6 Insphero
13.6.1 Insphero Company Information
13.6.2 Insphero Heart Organ Chip Product Portfolios and Specifications
13.6.3 Insphero Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Insphero Main Business Overview
13.6.5 Insphero Latest Developments
13.7 Ascendance Bio
13.7.1 Ascendance Bio Company Information
13.7.2 Ascendance Bio Heart Organ Chip Product Portfolios and Specifications
13.7.3 Ascendance Bio Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ascendance Bio Main Business Overview
13.7.5 Ascendance Bio Latest Developments
13.8 Axosim
13.8.1 Axosim Company Information
13.8.2 Axosim Heart Organ Chip Product Portfolios and Specifications
13.8.3 Axosim Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Axosim Main Business Overview
13.8.5 Axosim Latest Developments
13.9 Hurel
13.9.1 Hurel Company Information
13.9.2 Hurel Heart Organ Chip Product Portfolios and Specifications
13.9.3 Hurel Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hurel Main Business Overview
13.9.5 Hurel Latest Developments
13.10 Synvivo
13.10.1 Synvivo Company Information
13.10.2 Synvivo Heart Organ Chip Product Portfolios and Specifications
13.10.3 Synvivo Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Synvivo Main Business Overview
13.10.5 Synvivo Latest Developments
13.11 Nortis Bio
13.11.1 Nortis Bio Company Information
13.11.2 Nortis Bio Heart Organ Chip Product Portfolios and Specifications
13.11.3 Nortis Bio Heart Organ Chip Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Nortis Bio Main Business Overview
13.11.5 Nortis Bio Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

LP Information社の医療分野での最新刊レポート

本レポートと同じKEY WORD（chip）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.